Trial Profile
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 02 Aug 2019
Price :
$35
*
At a glance
- Drugs Ubidecarenone (Primary)
- Indications Progressive supranuclear palsy
- Focus Therapeutic Use
- 11 Aug 2015 New trial record
- 23 Jun 2015 Results presented at the 1st Congress of the European Academy of Neurology.